US Stock MarketDetailed Quotes

Corbus Pharmaceuticals (CRBP)

Watchlist
  • 10.300
  • +0.420+4.25%
Close May 1 16:00 ET
  • 10.250
  • -0.050-0.48%
Post 20:01 ET
182.69MMarket Cap-1.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corbus Pharmaceuticals (CRBP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
75.10%85.31M
74.26%21.97M
57.48%24.42M
74.30%19.15M
105.50%19.78M
8.08%48.72M
24.75%12.61M
63.42%15.51M
34.18%10.99M
-44.37%9.62M
Selling and administrative expenses
-7.78%15.22M
-6.76%3.56M
-24.27%3.56M
-3.83%3.97M
7.04%4.13M
18.61%16.5M
22.22%3.82M
59.93%4.7M
4.64%4.12M
-1.22%3.86M
-General and administrative expense
-7.78%15.22M
-6.76%3.56M
-24.27%3.56M
-3.83%3.97M
7.04%4.13M
18.61%16.5M
22.22%3.82M
59.93%4.7M
4.64%4.12M
-1.22%3.86M
Research and development costs
117.54%70.1M
109.47%18.41M
93.01%20.86M
121.22%15.19M
171.47%15.64M
3.38%32.22M
25.89%8.79M
64.98%10.81M
61.57%6.87M
-56.96%5.76M
Operating profit
-75.10%-85.31M
-74.26%-21.97M
-57.48%-24.42M
-74.30%-19.15M
-105.50%-19.78M
-8.08%-48.72M
-24.75%-12.61M
-63.42%-15.51M
-34.18%-10.99M
44.37%-9.62M
Net non-operating interest income expense
24.58%5.53M
-20.79%1.41M
-26.08%1.13M
38.61%1.31M
789.42%1.68M
299.77%4.44M
35,700.00%1.78M
299.48%1.52M
222.16%948K
127.88%189K
Non-operating interest income
-12.38%5.53M
-20.79%1.41M
-40.88%1.13M
-17.88%1.31M
63.52%1.68M
285.76%6.31M
92.43%1.78M
776.96%1.9M
589.66%1.6M
--1.03M
Non-operating interest expense
--0
--0
--0
--0
--0
-51.48%1.87M
--0
-61.12%381K
-35.32%652K
--839K
Total other finance cost
----
----
----
----
----
----
----
----
----
-73.89%177.02K
Other net income (expense)
-69.48%1.24M
-99.92%1K
-125.00%-50K
309.30%176K
-55.98%1.12M
51.08%4.07M
-37.95%1.3M
1.01%200K
-76.24%43K
1,001.05%2.54M
Gain on sale of security
----
----
----
----
----
----
----
1,105.00%201K
2,200.00%42K
-1,213.74%-8.11K
Other non- operating income (expenses)
-69.48%1.24M
-99.92%1K
-125.00%-50K
309.30%176K
-55.98%1.12M
51.08%4.07M
-37.32%1.3M
-8.26%200K
-76.50%43K
1,004.54%2.54M
Income before tax
-95.32%-78.54M
-115.69%-20.56M
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
Income tax
Net income
-95.32%-78.54M
-115.69%-20.56M
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
Net income continuous Operations
-95.32%-78.54M
-115.69%-20.56M
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
Minority interest income
Net income attributable to the parent company
-95.32%-78.54M
-115.69%-20.56M
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-95.32%-78.54M
-115.69%-20.56M
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
Basic earnings per share
-60.33%-5.9
-60.26%-1.25
-65.22%-1.9
-60.00%-1.44
-67.47%-1.39
64.31%-3.68
56.42%-0.78
49.34%-1.15
56.10%-0.9
80.42%-0.83
Diluted earnings per share
-60.33%-5.9
-60.26%-1.25
-65.22%-1.9
-60.00%-1.44
-67.47%-1.39
64.31%-3.68
56.42%-0.78
49.34%-1.15
56.10%-0.9
80.42%-0.83
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 75.10%85.31M74.26%21.97M57.48%24.42M74.30%19.15M105.50%19.78M8.08%48.72M24.75%12.61M63.42%15.51M34.18%10.99M-44.37%9.62M
Selling and administrative expenses -7.78%15.22M-6.76%3.56M-24.27%3.56M-3.83%3.97M7.04%4.13M18.61%16.5M22.22%3.82M59.93%4.7M4.64%4.12M-1.22%3.86M
-General and administrative expense -7.78%15.22M-6.76%3.56M-24.27%3.56M-3.83%3.97M7.04%4.13M18.61%16.5M22.22%3.82M59.93%4.7M4.64%4.12M-1.22%3.86M
Research and development costs 117.54%70.1M109.47%18.41M93.01%20.86M121.22%15.19M171.47%15.64M3.38%32.22M25.89%8.79M64.98%10.81M61.57%6.87M-56.96%5.76M
Operating profit -75.10%-85.31M-74.26%-21.97M-57.48%-24.42M-74.30%-19.15M-105.50%-19.78M-8.08%-48.72M-24.75%-12.61M-63.42%-15.51M-34.18%-10.99M44.37%-9.62M
Net non-operating interest income expense 24.58%5.53M-20.79%1.41M-26.08%1.13M38.61%1.31M789.42%1.68M299.77%4.44M35,700.00%1.78M299.48%1.52M222.16%948K127.88%189K
Non-operating interest income -12.38%5.53M-20.79%1.41M-40.88%1.13M-17.88%1.31M63.52%1.68M285.76%6.31M92.43%1.78M776.96%1.9M589.66%1.6M--1.03M
Non-operating interest expense --0--0--0--0--0-51.48%1.87M--0-61.12%381K-35.32%652K--839K
Total other finance cost -------------------------------------73.89%177.02K
Other net income (expense) -69.48%1.24M-99.92%1K-125.00%-50K309.30%176K-55.98%1.12M51.08%4.07M-37.95%1.3M1.01%200K-76.24%43K1,001.05%2.54M
Gain on sale of security ----------------------------1,105.00%201K2,200.00%42K-1,213.74%-8.11K
Other non- operating income (expenses) -69.48%1.24M-99.92%1K-125.00%-50K309.30%176K-55.98%1.12M51.08%4.07M-37.32%1.3M-8.26%200K-76.50%43K1,004.54%2.54M
Income before tax -95.32%-78.54M-115.69%-20.56M-69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M
Income tax
Net income -95.32%-78.54M-115.69%-20.56M-69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M
Net income continuous Operations -95.32%-78.54M-115.69%-20.56M-69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M
Minority interest income
Net income attributable to the parent company -95.32%-78.54M-115.69%-20.56M-69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -95.32%-78.54M-115.69%-20.56M-69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M
Basic earnings per share -60.33%-5.9-60.26%-1.25-65.22%-1.9-60.00%-1.44-67.47%-1.3964.31%-3.6856.42%-0.7849.34%-1.1556.10%-0.980.42%-0.83
Diluted earnings per share -60.33%-5.9-60.26%-1.25-65.22%-1.9-60.00%-1.44-67.47%-1.3964.31%-3.6856.42%-0.7849.34%-1.1556.10%-0.980.42%-0.83
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -